Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

MEDIASRES · Novel Statistical Methodology for Diagnostic/Prognostic and Therapeutic Studies and Systematic Reviews

FP7Status: CLOSED1 January 201231 December 2015EU funding €3,935,114

Novel statistical methodology promises to greatly facilitate development of approaches for personalised medicine. While state-of-the-art statistical techniques have already advanced clinical trials and diagnostic/prognostic studies as the major source of evidence in clinical medicine, increasing availability of molecular techniques holds an even greater promise. However, for leveraging such information for individualised diagnosis/prognosis, and treatment, the corresponding complex structures have to be adequately modelled and results have to be aggregated by corresponding advanced meta-analytic approaches. The main goal of the project is to establish a joint research-training programme by an interdisciplinary and intersectorial network for providing early-stage researchers with deep insight into cutting-edge statistical methodology. The research area of statistical methodology for diagnostic/prognostic and therapeutic studies and systematic reviews is well suited for early-stage training purposes, as it comprises a wide range of theoretical and applied biostatistical tools that need to be mastered, further developed, and translated into clinical research and practice. Europe-wide exchanges will also be ensured to meet the need for mobility in today’s globalised society. Further career relevant knowledge and skills will be provided through a structured design of education. The early-stage researchers will be trained according to an individually supervised, comprehensive and complementary programme. The structure of these activities is based on the training-through-research approach of the network. The collaboration of leading biostatistical experts will stimulate the discovery of promising statistical methodology useful for the design and analysis of clinical research. The integration of full industry partners and clinical advisors in the network enables optimal conditions for research driven by application, which will ensure tangible benefits of the programme.

Consortium · 10 organisations

coordinator

UNIVERSITAETSKLINIKUM FREIBURG

DE · €896,160

participant

ACADEMISCH ZIEKENHUIS LEIDEN

NL · €526,990

participant

GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED

UK · €280,861

participant

NOVARTIS PHARMA AG

CH · €528,884

participant

UNIVERSITAET BERN

CH · €264,442

participant

KOBENHAVNS UNIVERSITET

DK · €309,910

participant

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER

UK · €280,861

participant

H. LUNDBECK AS

DK · €309,910

participant

UNIVERSITETET I OSLO

NO · €289,229

participant

UNIVERSIDAD DE VIGO

ES · €247,867

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.